<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-RWA-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Rwanda (le): Aide cibl&#xE9;e aux pays</narrative>
   <narrative xml:lang="EN">Rwanda: Targeted country assistance</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Plans d&#x2019;assistance technique cibl&#xE9;e aux pays L&#x2019;assistance technique cibl&#xE9;e aux pays (TCA) est octroy&#xE9;e sous forme de ressources destin&#xE9;es aux partenaires pr&#xE9;sents dans les pays. La TCA est un &#xE9;l&#xE9;ment du cadre d&#x2019;engagement avec les partenaires (PEF) de Gavi. Le plan de TCA d&#x2019;un pays est &#xE9;tablie selon les besoins exprim&#xE9;s du dit pays lors de l&#x2019;&#xE9;valuation conjointe. Un plan comprend une liste d&#x2019;activit&#xE9;s, d&#x2019;&#xE9;tapes cl&#xE9;s, et un budget pour une ann&#xE9;e dite.  L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Targeted country assistance (TCA) are resources provided to in-country partners under Gavi&#x2019;s partners&#x2019; engagement framework (PEF). A country&#x2019;s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <participating-org ref="US-EIN-27-1414646" role="4" type="21">
   <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">Edes &amp; Assoc Consultants Ltd</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Rwanda</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="RW" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="RW" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Kigali</narrative>
   </name>
   <administrative code="RW" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>-1.94995 30.05885</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">806650</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1073671</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">776383</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">58393</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="RWAPEF-TCA-EDES2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">22701</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-EDES (Edes &amp; Assoc Consultants Ltd)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Edes &amp; Assoc Consultants Ltd</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="RWAPEF-TCA-UNI OF OSLO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">7842</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="RWAPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">439560</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="RWAPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">336547</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="RWAPEF-TCA-EDES2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-EDES (Edes &amp; Assoc Consultants Ltd)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Edes &amp; Assoc Consultants Ltd</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="RWAPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">51644</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="RWAPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">585618</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="RWAPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">436409</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="RWAPEF-TCA-CHAI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">126587</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="RWAPEF-TCA-EDES2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">150</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-EDES (Edes &amp; Assoc Consultants Ltd)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Edes &amp; Assoc Consultants Ltd</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="RWAPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">123582</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="RWAPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">266026</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="RWAPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">260039</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="RWAPEF-TCA-CHAI2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">58393</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001510">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-12"></transaction-date>
   <value currency="USD" value-date="2021-07-12">19008</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003330">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-15"></transaction-date>
   <value currency="USD" value-date="2021-07-15">49186</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001059">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">2751</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EDES (Edes &amp; Assoc Consultants Ltd)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Edes &amp; Assoc Consultants Ltd</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900002528">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">7000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EDES (Edes &amp; Assoc Consultants Ltd)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Edes &amp; Assoc Consultants Ltd</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000990">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-17"></transaction-date>
   <value currency="USD" value-date="2019-12-17">12800</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EDES (Edes &amp; Assoc Consultants Ltd)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Edes &amp; Assoc Consultants Ltd</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">150</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EDES (Edes &amp; Assoc Consultants Ltd)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Edes &amp; Assoc Consultants Ltd</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-150</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EDES (Edes &amp; Assoc Consultants Ltd)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Edes &amp; Assoc Consultants Ltd</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-150</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EDES (Edes &amp; Assoc Consultants Ltd)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Edes &amp; Assoc Consultants Ltd</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">150</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EDES (Edes &amp; Assoc Consultants Ltd)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Edes &amp; Assoc Consultants Ltd</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">6938</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001283">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-468</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-18"></transaction-date>
   <value currency="USD" value-date="2020-03-18">733</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001193">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-29"></transaction-date>
   <value currency="USD" value-date="2020-03-29">14911</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-22263</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">22263</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000297">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-03"></transaction-date>
   <value currency="USD" value-date="2021-02-03">11363</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004265">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">17719</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006613">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">31950</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000899">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">439560</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">439560</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">146058</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002681">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">266026</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000900">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">336547</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">336100</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">100309</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002722">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">260039</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework (PEF)</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-rwanda-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Rwanda 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-rwanda-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Rwanda 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-rwanda-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Rwanda 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-rwanda-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Rwanda 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-rwanda-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Rwanda 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-rwanda-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Rwanda 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-rwanda-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Rwanda 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-rwanda-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Rwanda 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-05-31"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/programmes-et-impact/types-de-soutien/pef">
   <title>
    <narrative xml:lang="EN">Cadre d&apos;engagement avec les partenaires</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">A travers le cadre d&#x2019;engagement avec les partenaires, les partenaires de l&#x2019;Alliance du Vaccin soutiennent les activit&#xE9;s de vaccination au niveau national</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Gavi&#x2019;s targeted country assistance aims to share our partners&#x2019; specialist skills with the countries we support</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">L&#x2019;aide cibl&#xE9;e aux pays de Gavi vise &#xE0; partager les comp&#xE9;tences sp&#xE9;cialis&#xE9;es de nos partenaires avec les pays que nous soutenons</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/programmes-impact/types-support/pef">
   <title>
    <narrative xml:lang="EN">Partners&apos; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through the partners&#x2019; engagement framework, Vaccine Alliance partners support countries&#x2019; immunisation activities</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="47122-RWA" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Les conditions sont d&#xE9;taill&#xE9;es dans le cadre d&apos;engagement des partenaires</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">One meeting organized for each committee Severe AEFI cases investigated and assessed for causality</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to organize AEFI, NVC and NITAG meetings and to conduct severe AEFI cases investigation">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">AEFI and NVC meeting organized. One serious AEFI case was investigated. NITAG meeting organized by early July 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">90% of  activities included in the EPI committees action plans is implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support MOH   to implement and  monitor   activities  of EPI committees including   NITAG, AEFI committee and NVC for measles elimination">
      <location ref="RW"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">This activity was not implemented due to COVID-19 outbreak. It was reprogrammed</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support MOH   to implement and  monitor   activities  of EPI committees including   NITAG, AEFI committee and NVC for measles elimination">
      <location ref="RW"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">This activity was not implemented due to COVID-19 outbreak. It was reprogrammed</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">VPD surveillance assessment performed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to conduct Congenital Rubella Syndrome retrospective (CRS) review and assess health facility ability to detect CRS cases">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Activity planned for Q1 2022</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data desk review or triangulation analysis performed (coverage, surveillance, operational, others)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct immunization data triangulation analysis">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Due to conflicting agenda related to COVID-19 vaccination, this activity has been rescheduled to Q1, 2022</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">New specific VPD surveillance system implemented or integrated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Monitor the performance of VPDs surveillance system at district level">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Integrated supportive supervision (ISS) on VPDs surveillance was conducted in 29 district hospitals, and 103 health centers. Sensitization and refresher of 406 health care providers on VPDs case definitions and surveillance indicators was completed.
Surveillance data entered in the data management system, cleaned and analyzed on monthly basis; and feedback was provided to district for action.
Organized and facilitated VPDs surveillance related meetings and workshops at national and subnational levels.
Built capacity of district hospital EPI and surveillance focal points on ISS and ODK for data collection. In total 42 district focal points were trained.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">-75 % of districts have developed standardized microplanning -First evaluation review meeting conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Support EPI to address gaps in REC microplanning and implementation in the context of reaching the under-immunized and unimmunized children (dissemination of REC guide and tools). 2. Support EPI to conduct bi-annual review of routine immunization and VPDs surveillance performance at provincial level">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Activity rescheduled</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">-100% of district developed and implement standardized Microplans
-Second performance review meeting conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Support EPI   to address gaps in REC microplanning and implementation in   the context of reaching the under-immunized and unimmunized children (dissemination of REC guide and tools).
2. Support EPI to conduct bi-annual review of routine immunization and VPDs surveillance  performance  at provincial level">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">REC guide and REC tools were developed and are awaiting for approval and dissemination. The activities planned included the workshops, meeting and travels for field mission to supervise the implementation of REC. The implementation was hampered by the occurrence of COVID-19 and measures put in place to control the outbreak including lockdowns, mass gathering and travel restrictions. The activities will be implemented in Q3, 2021</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Support EPI   to address gaps in REC microplanning and implementation in   the context of reaching the under-immunized and unimmunized children (dissemination of REC guide and tools).
2. Support EPI to conduct bi-annual review of routine immunization and VPDs surveillance  performance  at provincial level">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">REC guide and REC tools were developed and are awaiting for approval and dissemination. The activities planned included the workshops, meeting and travels for field mission to supervise the implementation of REC. The implementation was hampered by the occurrence of COVID-19 and measures put in place to control the outbreak including lockdowns, mass gathering and travel restrictions. The activities will be implemented in Q3, 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Plan of action implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Support EPI to conduct operational research that will identify    root causes of low and substandard coverage rates  (&gt; 100%)  in  priority districts  and  develop action plan to address  challenges.">
      <location ref="RW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">TThe activity was planned to identify root causes for low and substandard coverage in selected districts. However, the occurrence of COVID-19 delayed the implementation and affected the quality of immunization data that can be addressed by a deep assessment to understand the effects of COVID-19 on the immunization system delivery. This activity is not expected to be implemented within the remaining period.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Support EPI to conduct operational research that will identify    root causes of low and substandard coverage rates  (&gt; 100%)  in  priority districts  and  develop action plan to address  challenges.">
      <location ref="RW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">TThe activity was planned to identify root causes for low and substandard coverage in selected districts. However, the occurrence of COVID-19 delayed the implementation and affected the quality of immunization data that can be addressed by a deep assessment to understand the effects of COVID-19 on the immunization system delivery. This activity is not expected to be implemented within the remaining period.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Support EPI to conduct operational research that will identify root causes of low and substandard coverage rates (&gt; 100%) in priority districts and develop action plan to address challenges.">
      <location ref="RW"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">This activity was not implemented. Instead, an overall assessment of effect of COVID-19 on immunization delivery system is ongoing and will be completed by Dec 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Operational research completed and plan of action available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Support EPI to conduct operational research that will identify root causes of low and substandard coverage rates (&gt; 100%) in priority districts and develop action plan to address challenges.">
      <location ref="RW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The implementation of the operational research is challenging due to the changes caused by the COVID-19 in immunization coverage data and the current situation of the COVID-19 outbreak with movement restrictions to control the outbreak. The activity need to be revised to take into consideration the COVID-19 context. Given the remaining time, the activity is not expected to be implemented</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">-100% of district developed and implement standardized Microplans -Second performance review meeting conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Support EPI to address gaps in REC microplanning and implementation in the context of reaching the under-immunized and unimmunized children (dissemination of REC guide and tools). 2. Support EPI to conduct bi-annual review of routine immunization and VPDs surveillance performance at provincial level">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The review of immunization coverage by district and health center was conducted. District analyzed their immunization coverage data and gaps related to reporting, vaccination coverage, data quality, low coverage in health centers were identified. With the support of central level, district hospital developed action plans to address the gaps, and the national level will ensure follow up of the implementation. 
The microplanning sessions were not conducted as results of COVID-19 impact on the implementation of routine activities. The microplanning sessions have been scheduled to Q1 2022</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Equity assessment report</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to conduct equity assessment(develop TORs, Hiring Consultant,organize workshops, report dissemination)">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">CEA assessment completed, dissemination planned in Q32021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Coverage and Equity Improvement plan</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to conduct equity assessment(develop TORs, Hiring Consultant,organize workshops, report dissemination)">
      <location ref="RW"></location>
     </target>
     <actual value="Completed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The CEA is completed, Final report to be approved by MOH/RBC and dissemination will follow. the report will be shared with the SCM for further consideration.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to conduct equity assessment(develop TORs, Hiring Consultant,organize workshops, report dissemination)">
      <location ref="RW"></location>
     </target>
     <actual value="Completed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The CEA is completed, Final report to be approved by MOH/RBC and dissemination will follow. the report will be shared with the SCM for further consideration.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">3&#xA0;EPI staff trained</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support 2 EPI staff for short course on Vaccinology and 1 staff on medical engineering or CCE maintenance short course">
      <location ref="RW"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Re-programed due to Covid-19</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of vaccinators  are trained on electonic vaccines management</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Upgrade vaccine managment with electronic stock managment using DHIS2 (continue from 2019,  cascade training for vaccinators(504))">
      <location ref="RW"></location>
     </target>
     <actual value="Completed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Activity completed</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Upgrade vaccine managment with electronic stock managment using DHIS2 (continue from 2019,  cascade training for vaccinators(504))">
      <location ref="RW"></location>
     </target>
     <actual value="Completed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Activity completed</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">System re-design fully  implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support implementation of the imunization supply chain system redesign(continuing from 2019)">
      <location ref="RW"></location>
     </target>
     <actual value="Completed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Activity completed.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support implementation of the imunization supply chain system redesign(continuing from 2019)">
      <location ref="RW"></location>
     </target>
     <actual value="Completed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Activity completed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">CCE assessment report and CCE inventory updated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to conduct CCE assessment/CCE inventory following CCEOP-ODP implementation(develop TORs, Hiring consultant, dissemination of CCEA report)">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The CCEOP-ODP still ongoing, year 2 CCEs(41 from BMedical) delivered in May2021, distribution and installation started with June2021. Haier CCEs are expected in July 2021. The assessment is planned in Q4 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to conduct CCE assessment/CCE inventory following CCEOP-ODP implementation(develop TORs, Hiring consultant, dissemination of CCEA report)">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The CCEOP-ODP still ongoing, year 2 CCEs(41 from BMedical) delivered in May2021, distribution and installation started with June2021. Haier CCEs are expected in July 2021. The assessment is planned in Q4 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Regular&#xA0;meetings organized with approved minutes</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support developement of National Logistics Working group(Develop TOR, organise innitition workshops)">
      <location ref="RW"></location>
     </target>
     <actual value="Completed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The NILWG is operational since November 2020.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support developement of National Logistics Working group(Develop TOR, organise innitition workshops)">
      <location ref="RW"></location>
     </target>
     <actual value="Completed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The NILWG is operational since November 2020.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EVM implementation plan is on track</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support immunization services strenthening, the NILWG operationalization, evidences generation, supply chain strengthening and demand generation.">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Activity on good track: NILWG is operational, KAPB and CEA completed, System design under implementation and SBCC strategy is under development.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Systems in place to track vaccine stocks at all levels and corrective measures undertaken</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support immunization services strenthening, the NILWG operationalization, evidences generation, supply chain strengthening and demand generation.">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The NILWG is operational, the main role is to monitor the implementation of the EVMIP implementation. During this reporting period the system design phase 2 - concerning distribution of vaccines for 3 months stock to DH-is being implemented through PUSH system.
The NILWG is much involved in Covid-19 vaccines logistics and distribution including development of SOPs and specific vaccines guidelines.
For supply Strengthening, funds were mobilized to procure additional CCEs to fill the gap where the CCEOP did not cover especially for replacement of unfunctional and obsolete CCEs, procurement is ongoing using UNICEF own funds. 
The demand generation activities ongoing, for the immunization communication strategy the consultant is working on the comments from CO and RO and for IECs materials the institutional consultant is working on draft posters and scripts.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Measles elimination strategic plan and surveillance technical documents drafted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support RBC/ESR to produce measles and Rubella elimination strategic plan (5 years), revise and disseminate surveillance technical documents">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Activity rescheduled</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">IPV catch-up campaign smoothly  implemented with 95%  of IPV  SIAs coverage</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support  for planning and monitoring  the implementation of IPV campaign">
      <location ref="RW"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The IPV catch-up campaign rescheduled</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support  for planning and monitoring  the implementation of IPV campaign">
      <location ref="RW"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The IPV catch-up campaign rescheduled</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to build capacity of EPI committees through training and participation in international workshop">
      <location ref="RW"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The campaign has been rescheduled</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to build capacity of EPI committees through training and participation in international workshop">
      <location ref="RW"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The campaign has been rescheduled</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Measles elimination strategic plan and surveillance technical documents  disseminated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support RBC/ESR to produce measles and Rubella  elimination strategic plan (5 years), revise and disseminate   surveillance technical documents">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The implementation of this activity delayed. Plan has been revised to reschedule the activity in quarter 3, 2021</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support RBC/ESR to produce measles and Rubella  elimination strategic plan (5 years), revise and disseminate   surveillance technical documents">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The implementation of this activity delayed. Plan has been revised to reschedule the activity in quarter 3, 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Measles elimination strategic plan and surveillance technical documents disseminated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support RBC/ESR to produce measles and Rubella elimination strategic plan (5 years), revise and disseminate surveillance technical documents">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The implementation of this activity was affected by COVID-19 response activities. It has been rescheduled to Q1 2022</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">3 sentinel sites established  and  4 Health care providers from each sentinel site  trained on CRS surveillance</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support ESR to revitalize Congenital Rubella Syndrome (CRS) Surveillance including the development of CRS related guiding documents, establishment of Surveillance sentinel sites and building capacity of HCP on the CRS surveillance">
      <location ref="RW"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">This activity was re-programmed. Retrospective review of data related to CRS cases and health facility assessment will be conducted prior to the establishing of and building capacity for surveillance sentinel sites</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support ESR to revitalize Congenital Rubella Syndrome (CRS) Surveillance including the development of CRS related guiding documents, establishment of Surveillance sentinel sites and building capacity of HCP on the CRS surveillance">
      <location ref="RW"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">This activity was re-programmed. Retrospective review of data related to CRS cases and health facility assessment will be conducted prior to the establishing of and building capacity for surveillance sentinel sites</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">National Guidelines and SOPs developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support ESR to revitalize Congenital Rubella Syndrome (CRS) Surveillance including the development of CRS related guiding documents, establishment of Surveillance sentinel sites and building capacity of HCP on the CRS surveillance">
      <location ref="RW"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="RW"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.100% of nurses are trained, 
2. Immunization e-tracker documented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implementation of immunization e-tacker: 1. Training of additional staffs (504 nurses)2.documentation of the implementation of immunization e-tracker">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The documentation on e-tracker is on going, draft report report shared for comments. To ensure improvement are of the e-tracker the training will be planned based on the findings of the assessment; recommendations and lessons will be used to improve on the training content and organization.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implementation of immunization e-tacker: 1. Training of additional staffs (504 nurses)2.documentation of the implementation of immunization e-tracker">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The documentation on e-tracker is on going, draft report report shared for comments. To ensure improvement are of the e-tracker the training will be planned based on the findings of the assessment; recommendations and lessons will be used to improve on the training content and organization.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% of nurses are trained</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implementation of immunization e-tacker: 1. Training of additional staffs (504 nurses)2.documentation of the implementation of immunization e-tracker">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The documentation on e-tracker is on going, draft report report shared for comments. To ensure improvement are of the e-tracker the training will be planned based on the findings of the assessment; recommendations and lessons will be used to improve on the training content and organization.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Policy &amp; Regulatory Environment</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">AEFI crisis management plan disseminated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support for the development of AEFI  crisis management  plan">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">AEFI crisis management plan has been drafted and is under review. The completion and dissemination of the plan was delayed as consequence of COVID-19 outbreak</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support for the development of AEFI  crisis management  plan">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">AEFI crisis management plan has been drafted and is under review. The completion and dissemination of the plan was delayed as consequence of COVID-19 outbreak</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support for the development of AEFI crisis management plan">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The drafting of AEF crisis management plan has been completed. The plan is under review</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">AEFI crisis management plan drafted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support for the development of AEFI crisis management plan">
      <location ref="RW"></location>
     </target>
     <actual value="Completed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The drafting of AEFI crisis management plan has been completed. The draft is under review</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of target sites achieving readiness to receive cold chain (e.g. equipment on site, ready and w/ trained staff).</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support MOH to rollout CCEOP-ODP2, VLMIS, vaccines temperature monitoring at all level)">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Activity on good track, ODP2 implementation started this June 2021 and electronic-VLMS is ongoing</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Draft TOR for CCEOP post implementation eveluation developed and shared with MOH</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="To conduct CCEOP-ODP post implementation evaluation">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Planned in Q4 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">80% of target sites (district hospitals, health centers) that have implemeted the ODP2</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support MOH to rollout CCEOP-ODP2, VLMIS, vaccines temperature monitoring at all level)">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The CCEOP implementation is fully implemented, report attached.
The new eVLMIS development is on track, all 45 EPI managers at DH and 2 nurses from the 507 health centers are trained on the new DHIS2 module on vaccine management. 
Stock management is updated monthly and timely shared with RO, all KPIs included.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">TOR approved, recruitement of consultant innitiated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="To conduct CCEOP-ODP post implementation evaluation">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The post implementation evaluation of CCEOP is postponed for next year due to delays in implementation. Draft TORs available, discussed at technical level.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EPI reviews and Joint Appraisals are well managed ensuring availability of relevant data to track progress</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning monitoring and evaluation of immunization service delivery towards reaching zero dose and underimmunized children, including the develoment of immunization policy, cMYP 2022-2026, performance review and documentation">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The situation analysis to inform the National Immunization policy and strategy is planned early December 2021. The first review of the performance of districts and health center is scheduled to take place in Q2 2022. These activity have been rescheduled due to conflicting agenda of COVID-19 vaccination roll out</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">42 district hospitals visited, 
health facility based  data verification and data management system  assessement completed
Immunization e-registry evaluation  completed and report disseminated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to monitor and  evaluate the implementation of immunization  e-registry at health center levels,  and conduct annual review of immunization  data quality and use">
      <location ref="RW"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The activity was re-programmed as the implementation was not feasible due to COVID-19 outbreak</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to monitor and  evaluate the implementation of immunization  e-registry at health center levels,  and conduct annual review of immunization  data quality and use">
      <location ref="RW"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The activity was re-programmed as the implementation was not feasible due to COVID-19 outbreak</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training of users completed and the system is functional</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Initiate e-case based surveillance to improve timeliness of measles case notification and investigation">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The development of the system and the training of trainers for the use of the system have been completed. Cascade training of District hospitals and health center planned and will be completed in Dec 2021</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Initiate e-case based surveillance to improve timeliness of measles  case notification and investigation">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The establishment of e-case based surveillance system is initiated. Plan of activities and concept note are drafted. Training of ToT and end users is scheduled in Q3,2021</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Initiate e-case based surveillance to improve timeliness of measles  case notification and investigation">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The establishment of e-case based surveillance system is initiated. Plan of activities and concept note are drafted. Training of ToT and end users is scheduled in Q3,2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">System developed and tested</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Initiate e-case based surveillance to improve timeliness of measles case notification and investigation">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The system is under development. Will be tested once finalized.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">10 Manuscripts submited to journals, annual immunization  bulletin disseminated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support  to document immunization best practices  through dissemination of regular   immunization bulletin and articles in international journals">
      <location ref="RW"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="RW"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support  to document immunization best practices  through dissemination of regular   immunization bulletin and articles in international journals">
      <location ref="RW"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="RW"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Sustainability study completed, EPI sustainability plan and EPI evidence document produced  to be used for advocacy for increased immunization financing</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to carry out sustainable immunization financing study,   document the evidence in support of continued and increased investment, and develop financial sustainability plan for the VPD / EPI program">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Activity delayed. Implementation rescheduled in Q3, 2021</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to carry out sustainable immunization financing study,   document the evidence in support of continued and increased investment, and develop financial sustainability plan for the VPD / EPI program">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Activity delayed. Implementation rescheduled in Q3, 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Sustainability study completed, EPI sustainability plan and EPI evidence document produced to be used for advocacy for increased immunization financing</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to carry out sustainable immunization financing study, document the evidence in support of continued and increased investment, and develop financial sustainability plan for the VPD / EPI program">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The Consultant to conduct immunization financing study has been recruited. The activities will start soon</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">ToRs developed and consultant recruited</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to carry out sustainable immunization financing study, document the evidence in support of continued and increased investment, and develop financial sustainability plan for the VPD / EPI program">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">ToRs have been drafted. The recruitment process ongoing</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Draft story lines developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support MOH in design and implementation of demand generation activities (key health practice messages development, story line workshop and radio production,community outreaches througth Itetero radio program/RBA partnership) and support to HPV catch-up">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Activity planned for next GOR fiscal year/ Coming TCA 2021 approved by Gavi, funds to be allocated from UNICEF HQ.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Development of communication strategy is initiated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to develop Immunization communication strategy(Develop Tor, Hiring consultant, organize workshop and dissemination)">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Consultant is on-board</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Strategic document developed and aprouved for dissemination</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to develop Immunization communication strategy(Develop Tor, Hiring consultant, organize workshop and dissemination)">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Consultant started the development of SBCC strategy under direct guidance of C4D/CAP section .</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to develop Immunization communication strategy(Develop Tor, Hiring consultant, organize workshop and dissemination)">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Consultant started the development of SBCC strategy under direct guidance of C4D/CAP section .</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Informed communication strategic plan developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support KABP study(continue from 2019)">
      <location ref="RW"></location>
     </target>
     <actual value="Completed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">KAPB study completed, Final report shared with MOH/RBC , Gavi and UNICEF RO.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support KABP study(continue from 2019)">
      <location ref="RW"></location>
     </target>
     <actual value="Completed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">KAPB study completed, Final report shared with MOH/RBC , Gavi and UNICEF RO.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">IEC materials/booklet developed and aproved</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to develop evidence based IEC materials including health workers communication tools">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The recruitment of the institutional consultant to develop IEC materials is ongoing.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Multi-media campaign on Immunization implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support MOH in design and implementation of demand generation activities (key health practice messages development, story line workshop and radio production,community outreaches througth Itetero radio program/RBA partnership) and support to HPV catch-up">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">UNICEF and RBC agreed on the on the plans, a workshop for story lining &amp;message development for both RI and HPV is being planned before December. HPV campaign is planned in December 2021, media campaign will be on before and during HPV vaccination planned in schools and communities.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">IEC Materials disseminated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to develop evidence based IEC materials including health workers communication tools">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">With support of C4D, the consultant is being recruited to develop the IEC materials.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to develop evidence based IEC materials including health workers communication tools">
      <location ref="RW"></location>
     </target>
     <actual value="On Track">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">With support of C4D, the consultant is being recruited to develop the IEC materials.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 85 % of districts are supervised</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support ESR to monitor VPDs surveillance">
      <location ref="RW"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">30% of district were visited.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Concept note and training materials developed, training participants invited</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support capacity building for Measles and Rubella laboratory and epidemiological surveillance and case investigation in the framework of measles elimination">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Activity rescheduled in Q3 2021 as consequence of COVID-19 and subsequent control measures limiting mass gathering, meetings and conferences, but also repurposing of responsible staff to respond to COVID-19</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of district hospital laboratory surveillance focal persons trained 42 medical officers and 42 IDSR focal persons from 42 district hospitals trained on measle case/outbreak investigation</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support capacity building for Measles and Rubella laboratory and epidemiological surveillance and case investigation in the framework of measles elimination">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Activity rescheduled in Q3 as consequence of COVID-19</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">40 clinicans from private clinics are trained on VPDs surveillance</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support  capacity building  for Measles and Rubella laboratory and epidemiological  surveillance and  case investigation  in the framework of measles elimination">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Activity rescheduled in Q3, 2021 as consequence of COVID-19</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support  capacity building  for Measles and Rubella laboratory and epidemiological  surveillance and  case investigation  in the framework of measles elimination">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Activity rescheduled in Q3, 2021 as consequence of COVID-19</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support capacity building for Measles and Rubella laboratory and epidemiological surveillance and case investigation in the framework of measles elimination">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The implementation of this activity was affected by COVID-19 response activities. It has been rescheduled to Q1 2022</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Concept note and ToRs for the development of the system developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Initiate e-case based surveillance to improve timeliness of measles case notification and investigation">
      <location ref="RW"></location>
     </target>
     <actual value="Completed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Concept note developed. HISP Rwanda has been engaged to provide support for the development of the system.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of district have implemented micro-plans based on annual measles operational plan</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support ESR to produce Measles elimination annual operational plan">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">Measles elimination operational plan was drafted but not implemented due to current COVID-19 outbreak and response activities</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Technical support from IST ESA identified and request submitted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support ESR to revitalize Congenital Rubella Syndrome (CRS) Surveillance including the development of CRS related guiding documents, establishment of Surveillance sentinel sites and building capacity of HCP on the CRS surveillance">
      <location ref="RW"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The activity was discussed with IST ESA and re-programmed to start with retrospective review of CRS cases in referral hospital and health facility assessment for the establishment of sentinel site</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The consultant to support the operational research is hired Plan of review meetings developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Support EPI to conduct operational research that will identify root causes of low and substandard coverage rates (&gt; 100%) in priority districts and develop action plan to address challenges.">
      <location ref="RW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">The implementation of the operational research is challenging due to the changes caused by the COVID-19 in immunization coverage data and the current situation of the COVID-19 outbreak with movement restrictions to control the outbreak. The activity need to be revised to take into consideration the COVID-19 context. Given the remaining time, the activity is not expected to be implemented.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">REC assessment completed and Bottlenecks identified and action plan to address the gaps developed - quarterly reports demonstrating impact to be shared with Gavi when reporting 6-monthly on milestones</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the EPI to evaluate the implementation of REC">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">This activity delayed as the implementation coincided with the preparation of COVID-19 vaccine introduction. All the staff involved were repurposed to support the COVID-19 vaccination</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Desk review and measles situation analysis completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support RBC/ESR to produce measles and Rubella elimination strategic plan (5 years), revise and disseminate surveillance technical documents">
      <location ref="RW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="RW"></location>
      <comment>
       <narrative xml:lang="EN">This activity has been rescheduled</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">ToRs for consultant developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support for the development of AEFI crisis management plan">
      <location ref="RW"></location>
     </target>
     <actual value="Completed">
      <location ref="RW"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">REC evaluation results disseminated Plan of action developed for REC microplanning develpment elaborated Plan of review meetings developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Support EPI to address gaps in REC microplanning and implementation in the context of reaching the under-immunized and unimmunized children (dissemination of REC guide and tools). 2. Support EPI to conduct bi-annual review of routine immunization and VPDs surveillance performance at provincial level">
      <location ref="RW"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="RW"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Covid-19 digital package installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="RW"></location>
     </target>
     <actual value="Completed">
      <location ref="RW"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Immunisation registry digital package configured and installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of immunisation registries">
      <location ref="RW"></location>
     </target>
     <actual value="Completed">
      <location ref="RW"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on COVID-19 digital data package and know how to use it.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="RW"></location>
     </target>
     <actual>
      <location ref="RW"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Immunisation registry piloted in one district.
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of immunisation registries">
      <location ref="RW"></location>
     </target>
     <actual>
      <location ref="RW"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
